Pecci, F., Jeng, M. Y., Federico, A. D., Mazzola, E., Peroni, M., Monaca, F., Mingo, E. C., Zullo, L., Marinelli, D., Colamartini, F., Riva, S. T., Le, M. T., Aijaz, A., Gariazzo, E., Makarem, M., Turgeman, I., LoPiccolo, J., Batra, U., Yu, H. A., Jänne, P. A. (2026). Clinicogenomic determinants of early progression on first-line osimertinib in
                    <i>EGFR</i>
                    -mutant NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8634